243 related articles for article (PubMed ID: 25859857)
21. [Risk factors and prognosis of node-positive cervical carcinoma].
Feng SY; Zhang YN; Liu JG
Ai Zheng; 2005 Oct; 24(10):1261-6. PubMed ID: 16219145
[TBL] [Abstract][Full Text] [Related]
22. [Contribution of neoadjuvant chemotherapy for operability of cancers of the uterine cervix].
Sláma J; Cibula D; Freitag P; Fischerová D; Janousek M; Pavlista D; Strunová M; Zikán M; Jancárková N
Ceska Gynekol; 2007 Apr; 72(2):116-9. PubMed ID: 17639733
[TBL] [Abstract][Full Text] [Related]
23. Histopathological findings in postoperative specimens in cervical cancer patients with stages IB2-IVA after neoadjuvant chemotherapy and preoperative plus postoperative radiotherapy.
Kornovski Y; Gorchev G
J BUON; 2007; 12(1):57-63. PubMed ID: 17436403
[TBL] [Abstract][Full Text] [Related]
24. Matched-case comparison for the role of surgery in FIGO stage Ib1-IIa squamous cell carcinoma of cervix and suspicious para-aortic lymph node metastasis.
Kim HS; Park NH; Wu HG; Cho JY; Chung HH; Kim JW; Song YS; Kim SH; Kang SB
Ann Surg Oncol; 2009 Jan; 16(1):133-9. PubMed ID: 18979134
[TBL] [Abstract][Full Text] [Related]
25. Significance of numbers of metastatic and removed lymph nodes in FIGO stage IB1 to IIA cervical cancer: Primary surgical treatment versus neoadjuvant chemotherapy before surgery.
Kim HS; Kim JH; Chung HH; Kim HJ; Kim YB; Kim JW; Park NH; Song YS; Kang SB
Gynecol Oncol; 2011 Jun; 121(3):551-7. PubMed ID: 21334733
[TBL] [Abstract][Full Text] [Related]
26. Safety and Efficacy of Neoadjuvant Chemotherapy Followed by Radical Surgery Versus Radical Surgery Alone in Locally Advanced Cervical Cancer Patients.
Gong L; Zhang JW; Yin RT; Wang P; Liu H; Zheng Y; Lou JY; Peng ZL
Int J Gynecol Cancer; 2016 May; 26(4):722-8. PubMed ID: 26905330
[TBL] [Abstract][Full Text] [Related]
27. Laparoscopic lymph node dissection should be performed before fertility preserving treatment of patients with cervical cancer.
Vercellino GF; Piek JM; Schneider A; Köhler C; Mangler M; Speiser D; Chiantera V
Gynecol Oncol; 2012 Sep; 126(3):325-9. PubMed ID: 22704949
[TBL] [Abstract][Full Text] [Related]
28. Predictive Factors of Pelvic Lymph Node Metastasis in Early-Stage Cervical Cancer.
Nanthamongkolkul K; Hanprasertpong J
Oncol Res Treat; 2018; 41(4):194-198. PubMed ID: 29562222
[TBL] [Abstract][Full Text] [Related]
29. A prospective case-control study on the impact of neoadjuvant chemotherapy on surgery-related outcomes of laparoscopic radical hysterectomy.
Bogani G; Cromi A; Serati M; Di Naro E; Casarin J; Marconi N; Sturla D; Donadello N; Ghezzi F
Anticancer Res; 2014 Oct; 34(10):5703-8. PubMed ID: 25275077
[TBL] [Abstract][Full Text] [Related]
30. Young Cervical Cancer Patients May Be More Responsive than Older Patients to Neoadjuvant Chemotherapy Followed by Radical Surgery.
Zhou J; Li X; Huang K; Jia Y; Tang F; Sun H; Zhang Y; Zhang Q; Ma D; Li S
PLoS One; 2016; 11(2):e0149534. PubMed ID: 26901776
[TBL] [Abstract][Full Text] [Related]
31. Topographic distribution of lymph node metastasis in patients with stage IB1 cervical cancer: an analysis of 8314 lymph nodes.
Cai J; He X; Wang H; Dong W; Zhang Y; Zhao J; Willborn KC; Huang B; Wang Z; Jiang P
Radiat Oncol; 2021 Mar; 16(1):54. PubMed ID: 33743714
[TBL] [Abstract][Full Text] [Related]
32. When Does Neoadjuvant Chemotherapy Really Avoid Radiotherapy? Clinical Predictors of Adjuvant Radiotherapy in Cervical Cancer.
Papadia A; Bellati F; Bogani G; Ditto A; Martinelli F; Lorusso D; Donfrancesco C; Gasparri ML; Raspagliesi F
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S944-51. PubMed ID: 26268452
[TBL] [Abstract][Full Text] [Related]
33. Comparison of survival outcomes of neoadjuvant therapy and direct surgery in IB2/IIA2 cervical adenocarcinoma: a retrospective study.
Ouyang P; Cai J; Gui L; Liu S; Wu NY; Wang J
Arch Gynecol Obstet; 2020 May; 301(5):1247-1255. PubMed ID: 32221709
[TBL] [Abstract][Full Text] [Related]
34. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.
Watari H; Todo Y; Takeda M; Ebina Y; Yamamoto R; Sakuragi N
Gynecol Oncol; 2005 Mar; 96(3):651-7. PubMed ID: 15721407
[TBL] [Abstract][Full Text] [Related]
35. [Comparison of effectiveness between intra-arterial and intra-venous neoadjuvant chemotherapy in stage Ib2-IIb cervical carcinoma].
Cao DY; Yang JX; Shen K; Xiang Y; Pan LY; Lang JH; Wu M; Huang HF
Zhonghua Fu Chan Ke Za Zhi; 2008 Dec; 43(12):888-91. PubMed ID: 19134324
[TBL] [Abstract][Full Text] [Related]
36. [Results of different postoperative adjuvant therapies for stage Ib-IIa cervical carcinoma with risk factors].
Wen HW; Huang WP; Liu TY; Ma K; Tao X; Zhu LR; Liao QP
Zhonghua Fu Chan Ke Za Zhi; 2013 Dec; 48(12):920-4. PubMed ID: 24495686
[TBL] [Abstract][Full Text] [Related]
37. Is there a place for a less extensive radical surgery in locally advanced cervical cancer patients?
Scambia G; Ferrandina G; Distefano M; Fagotti A; Manfredi R; Zannoni GF; Mancuso S
Gynecol Oncol; 2001 Nov; 83(2):319-24. PubMed ID: 11606092
[TBL] [Abstract][Full Text] [Related]
38. Lymphatic spread of cervical cancer: an anatomical and pathological study based on 225 radical hysterectomies with systematic pelvic and aortic lymphadenectomy.
Benedetti-Panici P; Maneschi F; Scambia G; Greggi S; Cutillo G; D'Andrea G; Rabitti C; Coronetta F; Capelli A; Mancuso S
Gynecol Oncol; 1996 Jul; 62(1):19-24. PubMed ID: 8690286
[TBL] [Abstract][Full Text] [Related]
39. Lymph node involvement in locally advanced cervical cancer patients administered preoperative chemoradiation versus chemotherapy.
Ferrandina G; Distefano M; Ludovisi M; Morganti A; Smaniotto D; D'Agostino G; Fanfani F; Scambia G
Ann Surg Oncol; 2007 Mar; 14(3):1129-35. PubMed ID: 17206484
[TBL] [Abstract][Full Text] [Related]
40. Clinicopathological variables predictive of clinical outcome in patients with FIGO stage Ib2-IIb cervical cancer treated with cisplatin-based neoadjuvant chemotherapy followed by radical hysterectomy.
Gadducci A; Teti G; Barsotti C; Tana R; Fanucchi A; Orlandini C; Fabrini MG; Genazzani AR
Anticancer Res; 2010 Jan; 30(1):201-8. PubMed ID: 20150636
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
